Viridian Therapeutics, Inc.\DE

SUSQUEHANNA INTERNATIONAL GROUP, LLP VRDN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

116,524

Value ($000)

3,626

Weight

0.0%

2022 Q1 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	3,626	0.0%	116,524	12/31/2025
2025 Q3	11/14/2025	812	0.0%	37,640	9/30/2025
2025 Q2	8/14/2025	1,762	0.0%	126,023	6/30/2025
2025 Q1	5/14/2025	1,483	0.0%	109,984	3/31/2025
2024 Q4	2/14/2025	1,838	0.0%	95,865	12/31/2024
2024 Q3	11/14/2024	1,727	0.0%	75,909	9/30/2024
2024 Q2	8/15/2024	640	0.0%	49,211	6/30/2024
2024 Q1	5/7/2024	953	0.0%	54,440	3/31/2024
2023 Q4	2/14/2024	551	0.0%	25,318	12/31/2023
2023 Q3	11/14/2023	485	0.0%	31,647	9/30/2023
2023 Q2	8/11/2023	4,996	0.0%	209,996	6/30/2023
2023 Q1	5/16/2023	2,349	0.0%	92,326	3/31/2023
2022 Q4	2/14/2023	453	0.0%	15,504	12/31/2022
2022 Q3	11/14/2022	498	0.0%	24,286	9/30/2022
2022 Q2	8/15/2022	1,010	0.0%	87,254	6/30/2022
2022 Q1	5/16/2022	1,803	0.0%	97,527	3/31/2022